Estimation of post-vaccination antibody titre against goat pox and determination of protective antibody titre

Barman, D.; Chatterjee, Amaresh; Guha, C.; Biswas, U.; Sarkar, Jayanta; Roy, Tatiana; Roy, Barun; Baidya, Surajit

doi:10.1016/j.smallrumres.2010.04.028

Cited by 7 publications

(9 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to the results of this study, all calves in both vaccinated groups were able to produce antibodies in response to vaccine strains, and the neutralisation antibody titres of vaccinated calves were increased at each day of follow-up after DPV 7 and increased up to DPV 35. These findings are consistent with results obtained in other studies demonstrating that vaccinated calves produce neutralising antibodies before day 7 after vaccination (Barman et al, 2010;Khafagy et al, 2016). Vaccinated calves reached protective level (1.5) at DPV 21 that increased gradually to DPV 35.…”

Section: Discussionsupporting

confidence: 93%

Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle

Norian¹,

ahangran²,

Varshovi³

et al. 2019

BJVM

View full text Add to dashboard Cite

Norian, R., N. Afzal Ahangran, H. R. Varshovi & A. Azadmehr, 2019. Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle. Bulg. J. Vet. Med., 22, No 2,[171][172][173][174][175][176][177][178][179] This longitudinal study was performed for field trial of heterologous vaccine strains of lumpy skin disease (LSD) to provide details on the characteristics of induced immune responses by measurement of specific antibody and target cytokines -critical parameters in immune response that can be related to the durability of protection. The experimental calves were vaccinated with Gorgan-GPV and RM/65-SPV vaccines and humoral and cellular immunity were evaluated weekly. In each vaccinated groups, cross-neutralising antibody titers against LSD virus (LSDV) could be detected, and this rate in GGPV-vaccinated calves (GC) was higher than RSPV-vaccinated calves (RC) in all weeks of experiments. The stimulation index and IFN-γ and IL-4 production in response to homologous virus were higher than to the heterologous virus in all time points. The highest difference between them was observed in RVC, and a significant difference were only shown at 21-day post vaccination (DPV) (P<0.001). The results of this study indicated that GGPV-vaccine had a good immunogenic response due to induction of high antibody titre and higher lymphocyte proliferation and IFN-γ and IL-4 production. Therefore, it was considered suitable to control LSD.

show abstract

Section: Discussionsupporting

confidence: 93%

Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle

Norian¹,

ahangran²,

Varshovi³

et al. 2019

BJVM

View full text Add to dashboard Cite

show abstract

“…Для иммунизации коз часто применяют моновалентную вакцину против оспы овец, которая не предохраняет животных от заболевания. Аналогичные результаты получены при иммунизации овец моновалентной вирусвакциной против оспы коз [8]. При угрозе возникновения оспы овец и оспы коз более перспективным является применение ассоциированной вирусвакцины, которая способна в короткие сроки с наименьшими затратами предохранить животных от заболевания.…”

Section: Of Experimental Associated Virus Vaccine Against Sheep Pox Aunclassified

Antigenic and Protective Properties of Experimental Associated Virus Vaccine Against Sheep Pox and Goat Pox

Konstantinov¹,

Старов²,

Диев³

et al. 2018

Veterinariâ segodnâ

View full text Add to dashboard Cite

Studies have been carried on antigenic and protective activity of the experimental associated vaccine containing, in the field vaccination dose, antigens of the attenuated ARRIAH strain of the sheep pox virus and ARRIAH 2003 strain of the goat pox virus in the ratio of 4.24 and 4.24 lg TCD50/cm3, 4.18 and 4.37 lg TCD50/cm3and 4.37 and 4.18 lg TCD50/cm3respectively, as well as monovalent vaccines with the infectious activity of these strains with a titer of 4.5 lg TCD50/cm3. Administration of the associated virus vaccine did not adversely affect the physiological state of the animals and was accompanied by the formation of viral neutralizing antibodies in protective titres that did not differ from antibody titers in the blood of sheep and goats during monovalent immunization. High levels of virus neutralizing antibodies in the range of (3.50 ± 0.50)–(4.05 ± 0.22) and (3.58 ± 0.08)–(4.00 ± 0.29) log2respectively were determined in the blood serum of all sheep and goats vaccinated with associated vaccines. The antigenic activity of the associated vaccines for goats and sheep is almost identical. There were no negative effects on the antigenic activity of different ratios of attenuated strains of the sheep pox and goat pox virus in the inoculation dose. All sheep immunized with the monovalent vaccine against sheep and goat pox and associated virus vaccines, resisted the disease when challenged with a virulent sheep pox virus “Afghanistan” strain. Three sheep vaccinated with a monovalent vaccine against goat pox demonstrated a large local reaction, one sheep was diagnosed with generalized form of sheep pox.

show abstract

“…and reached the peak 21day P.V., then decline but persist within the protective levels. As well, Barmana et al (2010) showed that antibodies are increased above 1:16 titres at day 21 and reached peak (1:32) at 3 months and remain peak for 1 year post vaccination.…”

Section: Discussionmentioning

confidence: 78%

Study on the capability of a dual capripox vaccine in protection of cattle against LSD infection

Mikhael

Nakhla

Mohamed

2017

Journal of Veterinary Medical Research

View full text Add to dashboard Cite

The experiment applied on four groups of calves, each of four calves. Three calves from each group were vaccinated with one of the following attenuated vaccines: Lumpy skin disease vaccine (LSD), Romanian sheep pox (RSP) vaccine, Held goat pox (HGP) vaccine and dual (bivalent) vaccine of SPV and GPV. All vaccines were evaluated by estimating the cellular immunity using lymphocyte blastogenesis measured by XTT assay, and humeral immunity using serum neutralization and ELISA tests of vaccinated calves. The NI coincided with the ELISA antibody results and corroborated the results of cell mediated immunity which demonstrated the capacity of LSD and dual vaccines to induce immune response higher than SP vaccine and GP vaccines. In conclusion, the current study proved that the LSD and dual vaccines were highly immunogenic than the RSP and HGP vaccines, and dual vaccine could be safely used for vaccination of cattle against lumpy skin disease.

show abstract

Estimation of post-vaccination antibody titre against goat pox and determination of protective antibody titre

Cited by 7 publications

References 3 publications

Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle

Comparative efficacy of two heterologous capripox vaccines to control lumpy skin disease in cattle

Antigenic and Protective Properties of Experimental Associated Virus Vaccine Against Sheep Pox and Goat Pox

Study on the capability of a dual capripox vaccine in protection of cattle against LSD infection

Contact Info

Product

Resources

About